00853 MICROPORT
- 7.040
- 0.0000.00%
MICROPORT News
(Tama: For Minimally Invasive Healthcare 00853) The target price for the “Synchronize with the Market” rating was raised to HK$9
Damo's net loss forecast for Minimally Invasive Healthcare (00853) for this year and next two years will shrink by 4.8% and 13.1%, respectively.
MicroPort Scientific's 2023 Loss Widens Despite Revenue Growth
MicroPort Scientific's (HKG:0853) attributable loss widened to $477.6 million, or $0.2717 per share, in 2023, from $436.5 million, or $0.2494 per share, in 2022, according to the company's annual repo
2023年度報告
MicroPort Scientific Insiders Forfeit On 11% Gains After Selling Stock
Despite a 11% gain in MicroPort Scientific Corporation's (HKG:853) stock price this week, shareholders shouldn't let up. The fact that insiders chose to dispose of US$2.1m worth of stock in the past
Minimally Invasive Healthcare (00853): Cardiac Healthcare's net profit in the first quarter was about 184 million yuan, up 47.62% year-on-year
Minimally Invasive Healthcare (00853) announced the results of Cardiac Medical Technology for the first quarter of 2024, with revenue of about 358 million yuan, the same...
Xiaomo reduced its holdings of Minimally Invasive Healthcare (00853.HK) by about 7.6627 million shares at a price of about HK$5.74 per share
According to the latest data from the Hong Kong Stock Exchange, on April 15, Xiaomo reduced its holdings of Minimally Invasive Healthcare (00853.HK) by 7.6626.87 million shares, at a price of HK$5.7434 per share, for a total amount of about HK$440.99 million. After the holdings were reduced, the latest number of shares held was about 234 million shares, and the latest shareholding ratio was 12.75%.
Changes in Hong Kong stocks | Minimally Invasive Healthcare (00853) fell by more than 4% and recently received conditions from Gao Lin to relieve long-term debt problems, and it may still be difficult
Minimally Invasive Healthcare (00853) fell by more than 4%, and its stock price has fallen by more than 37% during the year. As of press release, it fell 4.17% to HK$5.28, with a turnover of HK$20.3597 million.
J.P. Morgan sold 7.6627 million shares of Minimally Invasive Healthcare (00853.HK), worth approximately HK$44.99 million
On April 18, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 18, JPMorgan Chase & Co. (JPMorgan Chase & Co.) sold $7.6627 million common shares worth approximately HK$44.99 million on April 15 at an average price of HK$5.7434 per share and an average OTC average price of HK$5.7383 per share. After the sale, J.P. Morgan Chase's latest shareholding was 234 million shares, and the good position ratio fell from 13.17% to 12.75%. Photo source: Stock Exchange share disclosure what is a right
Changes in Hong Kong stocks | Minimally Invasive Healthcare (00853) falls more than 5% to ease short-term debt pressure, Nomura says the long-term debt problem is still difficult
Minimally Invasive Medicine (00853) fell by more than 5%. As of press release, it fell 4.84% to HK$5.5, with a turnover of HK$28.9347 million.
Minimally Invasive Healthcare (00853.HK) received 467,200 additional shares of common stock from We'Tron Capital Limited, worth approximately HK$2,9701,400
On April 15, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 15, We'Tron Capital Limited increased its share holdings of $Minimally Invasive Healthcare (00853.HK) by $46.72 million at an average price of HK$6.36 per share on April 10, worth approximately HK$2,9714 million. After the increase in holdings, We'Tron Capital Limited's latest shareholding was 345 million shares, and the good position ratio increased from 18.80% to 18.83%. This transaction involves other related parties: Maxwell Maxcare
Hong Kong stocks are bullish this week | Electric power stocks are starting to soar! Huaneng International and Huadian International have increased by about 16% each week
Gold continued to soar, driving Hong Kong gold stocks to experience a strong rise. Zhaojin Mining surged more than 22% during the week.
Changes in Hong Kong stocks | Minimally Invasive Healthcare (00853.HK) fell nearly 4% at the end of the session, and the company received US$150 million in convertible financing Nomura says the long-term debt problem is still difficult
Minimally Invasive Healthcare (00853.HK) fell nearly 4% at the end of the session. As of press release, it was down 3.92% to HK$6.12, with a turnover of HK$49.6016 million.
When medical device giants are minimally invasive and struggling to save themselves | Focus
① Through the issuance of 150 million US dollars of convertible bonds and credit support of more than 300 million US dollars from financial institutions, the pressure to repay the remaining 448 million US dollars of convertible bonds from Minimally Invasive Healthcare has been relieved; ② Early redemption of 700 million US dollars of convertible bonds triggered the liquidity crisis of Minimally Invasive Healthcare, but it is not “a day of cold” that causes the company's current difficulties.
Nomura Adjusts MicroPort Scientific's Price Target to HK$6.71 From HK$7.19, Keeps at Neutral
03:34 AM EDT, 04/09/2024 (MT Newswires) -- Nomura Adjusts MicroPort Scientific's Price Target to HK$6.71 From HK$7.19, Keeps at Neutral Price (HKD): $6.56, Change: $-0.02, Percent Change: -0.30%
Nomura: Target price for Minimally Invasive Medicine (00853.HK) “neutral” rating reduced to HK$6.71
Nomura released a research report stating that the target price for minimally invasive medical treatment (00853.HK) was rated “neutral” and the target price was reduced by 7% from HK$7.19 to HK$6.71.
Minimally Invasive Healthcare (00853.HK) granted a total of 11.648,800 share options
Minimally Invasive Healthcare (00853.HK) issued an announcement. The board of directors of Minimally Invasive Medical Science Co., Ltd. granted a total of 11.648,800 share options to 46 eligible participants and two service providers to subscribe for up to 11.648,800 common shares with a face value of $0.00001 per share in accordance with the share plan adopted by the Company on June 19, 2023, accounting for approximately 0.635% of the company's issued share capital on the date of this announcement. The exercise price for which the share options were granted was HK$6.58 per share.
Minimally Invasive Healthcare (00853.HK): Implementation of the debt problem suggests focusing on subsequent loss reduction and payment
The 2023 results are in line with market expectations. The company announced 2023 results: revenue of US$950 million, excluding exchange rate impact +15.8% YoY; net loss to mother of US$480 million (US$440 million in 2022).
MicroPort Scientific to Receive $150 Million Loan Facility, $300 Million Credit Support to Repay Convertible Bonds
MicroPort Scientific (HKG:0853) will receive a $150 million convertible term loan facility from four lenders with an interest rate of 5.75% per annum and falling due in 60 months, an April 5 filing on
Minimally Invasive Healthcare (00853) reported 2023 annual results, and losses attributable to shareholders increased 9.4% year-on-year to US$478 million
Minimally Invasive Healthcare (00853) announced its annual results for the year ended December 31, 2023. The company's revenue was 9...
MICROPORT: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Analysis
Price Target
No Data
